Michael Hearne

Michael Hearne

Director of Finance/CFO at ODONATE, INC.

Net worth: 2 M $ as of 31/05/2026

63 year
Health Technology
Commercial Services
Consumer Services

Profile

Michael S.
Hearne
is currently Chief Financial Officer at Kezar Life Sciences, Inc. since 2026, Chief Financial Officer at Aurinia Pharmaceuticals, Inc. since 2026, and Chief Financial Officer at Odonate, Inc. since 2018.
Former roles include Managing Director & Principal at Carson Private Capital, Inc., Partner at Rothstein, Kass & Co. LLC from 2000 to 2008, Partner at Weaver & Tidwell LLP from 2014 to 2015, and Chief Financial & Accounting Officer at La Jolla Pharmaceutical Co. Education includes undergraduate and graduate degrees from Brigham Young University and an undergraduate degree from Texas A&M University conferred in 1989.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
18/05/2026 116,144 ( 0.09% ) 2 M $ 31/05/2026

Michael Hearne active positions

CompaniesPositionStart
ODONATE, INC. Director of Finance/CFO 19/11/2018
AURINIA PHARMACEUTICALS INC. Director of Finance/CFO 23/03/2026
KEZAR LIFE SCIENCES, INC. Director of Finance/CFO 11/05/2026

Former positions of Michael Hearne

CompaniesPositionEnd
Corporate Officer/Principal 01/01/2015
Corporate Officer/Principal 01/01/2008
LA JOLLA PHARMACEUTICAL COMPANY Director of Finance/CFO -
Private Equity Investor -
See the detail of Michael Hearne's experience

Training of Michael Hearne

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Hearne